Cargando…
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment
Microtubules and carbon nanotubes (CNTs), and more particularly multi-walled CNTs (MWCNTs), share many mechanical and morphological similarities that prompt their association into biosynthetic tubulin filaments both, in vitro and in vivo. Unlike CNTs, microtubules are highly dynamic protein polymers...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734827/ https://www.ncbi.nlm.nih.gov/pubmed/33317574 http://dx.doi.org/10.1186/s12951-020-00742-y |
_version_ | 1783622539538333696 |
---|---|
author | Hevia, Lorena García Fanarraga, Mónica L. |
author_facet | Hevia, Lorena García Fanarraga, Mónica L. |
author_sort | Hevia, Lorena García |
collection | PubMed |
description | Microtubules and carbon nanotubes (CNTs), and more particularly multi-walled CNTs (MWCNTs), share many mechanical and morphological similarities that prompt their association into biosynthetic tubulin filaments both, in vitro and in vivo. Unlike CNTs, microtubules are highly dynamic protein polymers that, upon interaction with these nanomaterials, display enhanced stability that has critical consequences at the cellular level. Among others, CNTs prompt ectopic (acentrosomal) microtubule nucleation and the disassembly of the centrosome, causing a dramatic cytoskeletal reorganization. These changes in the microtubule pattern trigger the generation of ineffective biomechanical forces that result in migration defects, and ultimately in spindle-assembly checkpoint (SAC) blockage and apoptosis. In this review, we describe the molecular mechanism involved in the intrinsic interference of CNTs with the microtubule dynamics and illustrate the consequences of this effect on cell biomechanics. We also discuss the potential application of these synthetic microtubule-stabilizing agents as synergetic agents to boost the effect of classical chemotherapy that includes spindle poisons (i.e. paclitaxel) or DNA interfering agents (5-fluorouracil)-, and list some of the advantages of the use of MWCNTs as adjuvant agents in preventing cell resistance to chemotherapy. [Image: see text] |
format | Online Article Text |
id | pubmed-7734827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77348272020-12-15 Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment Hevia, Lorena García Fanarraga, Mónica L. J Nanobiotechnology Review Microtubules and carbon nanotubes (CNTs), and more particularly multi-walled CNTs (MWCNTs), share many mechanical and morphological similarities that prompt their association into biosynthetic tubulin filaments both, in vitro and in vivo. Unlike CNTs, microtubules are highly dynamic protein polymers that, upon interaction with these nanomaterials, display enhanced stability that has critical consequences at the cellular level. Among others, CNTs prompt ectopic (acentrosomal) microtubule nucleation and the disassembly of the centrosome, causing a dramatic cytoskeletal reorganization. These changes in the microtubule pattern trigger the generation of ineffective biomechanical forces that result in migration defects, and ultimately in spindle-assembly checkpoint (SAC) blockage and apoptosis. In this review, we describe the molecular mechanism involved in the intrinsic interference of CNTs with the microtubule dynamics and illustrate the consequences of this effect on cell biomechanics. We also discuss the potential application of these synthetic microtubule-stabilizing agents as synergetic agents to boost the effect of classical chemotherapy that includes spindle poisons (i.e. paclitaxel) or DNA interfering agents (5-fluorouracil)-, and list some of the advantages of the use of MWCNTs as adjuvant agents in preventing cell resistance to chemotherapy. [Image: see text] BioMed Central 2020-12-14 /pmc/articles/PMC7734827/ /pubmed/33317574 http://dx.doi.org/10.1186/s12951-020-00742-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Hevia, Lorena García Fanarraga, Mónica L. Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment |
title |
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment |
title_full |
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment |
title_fullStr |
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment |
title_full_unstemmed |
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment |
title_short |
Microtubule cytoskeleton-disrupting activity of MWCNTs: applications in cancer treatment |
title_sort | microtubule cytoskeleton-disrupting activity of mwcnts: applications in cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734827/ https://www.ncbi.nlm.nih.gov/pubmed/33317574 http://dx.doi.org/10.1186/s12951-020-00742-y |
work_keys_str_mv | AT hevialorenagarcia microtubulecytoskeletondisruptingactivityofmwcntsapplicationsincancertreatment AT fanarragamonical microtubulecytoskeletondisruptingactivityofmwcntsapplicationsincancertreatment |